Burkitt Lymphoma Latest Advances

Find the Latest Research About Burkitt Lymphoma

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12115 publications

Epstein-Barr Virus Latent Membrane Protein 1 Suppresses Ferroptosis via Pentose Phosphate Pathway and Glutathione Metabolism.

Epstein-Barr Virus Latent Membrane Protein 1 Suppresses Ferroptosis via Pentose Phosphate Pathway and Glutathione Metabolism.

Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026

CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c.

CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c.

Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026

Why and How Epstein-Barr Virus Was Discovered 50 Years Ago.

Why and How Epstein-Barr Virus Was Discovered 50 Years Ago.

Journal: Current topics in microbiology and immunology
Published: March 25, 2026

Trends and projections of Burkitt Lymphoma burden (1990-2036): an analysis based on the global burden of disease study 2021.

Trends and projections of Burkitt Lymphoma burden (1990-2036): an analysis based on the global burden of disease study 2021.

Journal: Hematology (Amsterdam, Netherlands)
Published: March 20, 2026

EBNA1 Knockdown Modulates Proliferation, Apoptosis, and Metabolism in Burkitt's Lymphoma Cells by Downregulating miR-127-5p

EBNA1 Knockdown Modulates Proliferation, Apoptosis, and Metabolism in Burkitt's Lymphoma Cells by Downregulating miR-127-5p

Journal: Zhongguo shi yan xue ye xue za zhi
Published: March 18, 2026

Locus-specific proteomics identifies novel regulators of Epstein-Barr virus lytic reactivation.

Locus-specific proteomics identifies novel regulators of Epstein-Barr virus lytic reactivation.

Journal: Journal of virology
Published: March 17, 2026

Correction: Atypical Multisystemic Manifestations of Ascaris Infection in a Patient With Burkitt Lymphoma: A Fatal Diagnostic Challenge.

Correction: Atypical Multisystemic Manifestations of Ascaris Infection in a Patient With Burkitt Lymphoma: A Fatal Diagnostic Challenge.

Journal: Cureus
Published: March 02, 2026

RETRACTION: Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Practical Approach.

RETRACTION: Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Practical Approach.

Journal: Hematological oncology
Published: March 01, 2026

EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphoma.

EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphoma.

Journal: bioRxiv : the preprint server for biology
Published: February 23, 2026

Prospective Cohort Study Testing Interventions to Reduce Diagnosis Delay and Treatment Abandonment of Children With Burkitt Lymphoma in Kenya.

Prospective Cohort Study Testing Interventions to Reduce Diagnosis Delay and Treatment Abandonment of Children With Burkitt Lymphoma in Kenya.

Journal: JCO global oncology
Published: February 11, 2026

Pediatric Ileocecal Burkitt Lymphoma Presenting as a Diagnostic Challenge After a Nondiagnostic Surgical Biopsy: A Case Report.

Pediatric Ileocecal Burkitt Lymphoma Presenting as a Diagnostic Challenge After a Nondiagnostic Surgical Biopsy: A Case Report.

Journal: Cureus
Published: February 10, 2026

The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
Showing 1-12 of 12,115

Last Updated: 04/28/2026